SCHEMBL8623400

SCHEMBL8623400

CCOP(=O)(OCC)C(CCc1ccc(OCCc2ccccc2)cc1)CS(=O)(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
PPARG P37231 4/20 0.41
PPARA Q07869 1/20 0.41
LTA4H P09960 3/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
PTGES O14684 1/20 0.39
ALOX5 P09917 1/20 0.39
MAPT P10636 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8624041 0.88 FDFT1 (0.45) FFAR1PPARGPPARALTA4H
SCHEMBL8618660 0.88 POLB (0.42) LTA4HSMN1; SMN2MEN1KMT2A
SCHEMBL8625399 0.88 POLB (0.42) MEN1KMT2A
SCHEMBL8947010 0.84 S1PR1 (0.36) PPARGPPARA
SCHEMBL8623396 0.81 FFAR1 (0.45) FFAR1CA12CA1CA2CA7
SCHEMBL8622242 0.81 LPAR1 (0.39) FFAR1LTA4H
SCHEMBL8619659 0.80 EPHX2 (0.38) CA12CA1CA2CA9EPHX2
SCHEMBL8620662 0.70 FFAR1 (0.50) FFAR1CA12CA1CA2CA7
SCHEMBL8624761 0.70 S1PR1 (0.44)
SCHEMBL8947127 0.70 ACP3 (0.43) PPARGPPARAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed